ÇåÆÃÅϺ´ Ä¡·á ½ÃÀå, ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®°ú ¿¹Ãø(2024-2032³â)
Huntingtons Disease Treatment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
»óǰÄÚµå : 1570927
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 112 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,882,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,585,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 11,849,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÇåÆÃÅϺ´ Ä¡·á ½ÃÀåÀº 2023³â¿¡´Â 4¾ï 5,750¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â CAGRÀº 20.8%·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀå¿¡´Â ÇåÆÃÅϺ´ÀÇ À¯º´·ü Áõ°¡¿Í ÀÇÇÐ ¿¬±¸ÀÇ ´«ºÎ½Å ¹ßÀüÀÌ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Áø´Ü ÅøÀÇ °³¼±°ú ÀνÄÀÇ Çâ»óÀ¸·Î ´õ ¸¹Àº »ç·Ê°¡ È®ÀεǾî È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À¯ÀüÀÚ °Ë»çÀÇ ¹ßÀüÀ¸·Î ´õ ºü¸£°í Á¤È®ÇÑ Áø´ÜÀÌ °¡´ÉÇØÁ® Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Åׯ®¶óº£³ªµò°ú °°Àº ÁÖ¿ä Ä¡·áÁ¦ÀÇ Á¦³×¸¯ ÀǾàǰÀÌ Ãâ½ÃµÇ¸é¼­ Ä¡·áÀÇ Á¢±Ù¼ºÀÌ ³ô¾ÆÁ³½À´Ï´Ù. ¶ÇÇÑ Á¤ºÎ, Á¦¾à»ç ¹× ¹Î°£ ÅõÀÚÀÚÀÇ ÀÚ±Ý Áö¿ø°ú ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó »õ·Î¿î Ä¡·á¹ýÀÇ ¹ß°ß°ú °³¹ßÀÌ °¡¼ÓÈ­µÇ¾î ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¾à¹°À» Åׯ®¶óº£³ªÁø, µµÀÌÆ®¶óº£³ªÁø, ±âŸ ¾à¹°·Î ºÐ·ùÇϰí ÀÖÀ¸¸ç, 2023³â Åׯ®¶óº£³ªÁøÀÌ 47.8% ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Åׯ®¶óº£³ªµòÀº ÇåÆÃÅϺ´ÀÇ ÁÖ¿ä Áõ»óÀÎ ¹«µµº´ °ü¸®, ºñÀÚ¹ßÀû ¿îµ¿ ¾ïÁ¦, ¿îµ¿ ±â´É °³¼±¿¡ È¿°úÀûÀÔ´Ï´Ù. ÀÏÂïÀÌ ½ÂÀεǾî ÇåÆÃÅϺ´ÀÇ Æ¯È¿¾àÀ¸·Î ÀÎÁ¤¹ÞÀ¸¸é¼­ ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ È®°íÈ÷ Çß½À´Ï´Ù. ¿À¸®Áö³Î°ú Á¦³×¸¯ ÀǾàǰÀ» ¸ðµÎ »ç¿ëÇÒ ¼ö ÀÖÀ¸¹Ç·Î ºñ¿ë È¿À²ÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÏ¿© Å« ½ÃÀå Á¡À¯À²À» À¯ÁöÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â Ä¡·áÁ¦¸¦ ºê·£µå ÀǾàǰ°ú Á¦³×¸¯ ÀǾàǰÀ¸·Î ºÐ·ùÇϸç, 2023³â¿¡´Â ºê·£µå ÀǾàǰ ºÎ¹®ÀÌ È®¸³µÈ È¿´É°ú °­·ÂÇÑ ºê·£µå ÀÎÁöµµ¿¡ ÈûÀÔ¾î 2¾ï 5800¸¸ ´Þ·¯ ±Ô¸ð¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºê·£µå ÀǾàǰÀº Á¾ÇÕÀûÀÎ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ÀÓ»ó °¡À̵å¶óÀÎÀÇ ºó¹øÇÑ ÃßõÀ» ÅëÇØ ´Ù¾çÇÑ Áúº´¿¡ ´ëÇÑ Ç¥ÁØ Ä¡·áÁ¦·Î¼­ÀÇ ÀÔÁö¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ±¤¹üÀ§ÇÑ ¸¶ÄÉÆÃ Ä·ÆäÀΰú ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ·Î ºê·£µå Ä¡·áÁ¦ÀÇ ¸Å·ÂÀº ´õ¿í °­È­µÇ¾î ÀÇ·á ÇöÀåÀÇ ÃÖÀü¼±¿¡¼­ °è¼Ó À¯ÁöµÉ ¼ö ÀÖ½À´Ï´Ù.

2023³â ºÏ¹Ì ÇåÆÃÅϺ´ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â 1¾ï 8,390¸¸ ´Þ·¯·Î 20.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÏ¹Ì´Â ÇåÆÃÅϺ´ÀÇ À¯º´·üÀÌ ³ô°í, ÀÎÁöµµ°¡ ³ôÀ¸¸ç, Á¶±â Áø´Ü ´É·ÂÀÌ ¶Ù¾î³³´Ï´Ù. Áø´Ü ÅøÀÇ °³¼±°ú ÀÎ½Ä Á¦°í Ä·ÆäÀÎÀ¸·Î Áø´ÜÀ²ÀÌ ³ô¾ÆÁ® È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, 2023³â ¹Ì±¹ ÇåÆÃÅϺ´ Ä¡·á ½ÃÀåÀº 1¾ï 6,770¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2032³â¿¡´Â 8¾ï 9,440¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ì±¹Àº Á¦¾à ¿¬±¸°³¹ßÀÇ Áß½ÉÁöÀ̸ç, ÇåÆÃÅϺ´¿¡ ´ëÇÑ »õ·Î¿î Ä¡·á¹ý °³¹ß¿¡ ¸¹Àº ÅõÀÚ°¡ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ Áö¿ªÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¾àÁ¦º°, 2021-2032³â

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : À¯Çüº°, 2021-2032³â

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : À¯Åë ä³Îº°, 2021-2032³â

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

Á¦9Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Huntington's Disease Treatments Market was valued at USD 457.5 million in 2023, with a projected CAGR of 20.8% over 2024-2032. This growth is fueled by the increasing prevalence of Huntington's disease and significant advancements in medical research. Improved diagnostic tools and greater awareness have led to the identification of more cases, driving the demand for effective treatments. Advances in genetic testing now enable earlier and more accurate diagnoses, facilitating timely interventions. The availability of generic versions of key medications, such as tetrabenazine, has made treatments more affordable and accessible. Additionally, increased funding and investment from governments, pharmaceutical companies, and private investors, are accelerating the discovery and development of new therapies, further contributing to market expansion.

The overall huntingtons disease treatment industry is classified based on the drugs, type, distribution channel, and region.

The market categorizes drugs into tetrabenazine, deutetrabenazine, and other medications. In 2023, tetrabenazine dominated with a 47.8% market share. Tetrabenazine is effective for managing chorea, a major symptom of Huntington's disease, reducing involuntary movements, and improving motor function. Its early regulatory approval and recognition as a specific treatment for Huntington's disease solidifies its market position. Availability in both branded and generic forms provides cost-effective treatment options, maintaining its significant market share.

The market segments treatments into branded and generic categories. In 2023, the branded segment accounted for USD 258 million, driven by established efficacy and strong brand recognition. Branded medications benefit from comprehensive regulatory approval and frequent endorsements in clinical guidelines, reinforcing their position as standard treatments for various conditions. Extensive marketing campaigns and continued investment in research and development further strengthen the appeal of branded treatments, ensuring they remain at the forefront of medical practice.

In 2023, the North American market for Huntington's disease treatments was valued at USD 183.9 million, with a projected CAGR of 20.7%. North America has a high prevalence of Huntington's disease, coupled with increased awareness and early diagnostic capabilities. Improved diagnostic tools and awareness campaigns have led to higher diagnosis rates and greater demand for effective treatments. In 2023, the U.S. market for Huntington's disease treatments was valued at USD 167.7 million, projected to reach USD 894.4 million by 2032. The U.S. is a hub for pharmaceutical R&D, with significant investments in developing new therapies for Huntington's disease, supporting growth in the region.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Drugs, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 9 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â